The volume of announced deals involving UK targets in the first two quarters of the year fell 68.6% compared to the same period last year, leading to the quietest start to a calendar year for dealmaking since 2009.

At the half-year stage, US dealflow was down sharply whilst China was least impacted. Megadeals declined although mid-market showed resiliency. Meanwhile, private equity's global M&A market share reached record level.

Advisors seek consensus on how much to discount pre-crisis valuations.

Private equity firms have become increasingly interested in professional sports. 

Watch Mergermarket’s Virtual Event on the M&A market outlook in the CEE region here.

European M&A looks set to remain at historically low levels through 2020 with a recovery unlikely until mid-2021, as the world continues to grapple with the coronavirus pandemic and its economic consequences. 

The German economy is set to shrink by 10% in the three months to June as a result of the COVID-19 pandemic, but the DACH region is yet to see the effect of the pandemic on M&A value following several large transactions announced prior to the outbreak.

28 buyouts in the Technology and Business Services sectors were reported during March. 

As uncertainty surrounding the coronavirus pandemic began to hit corporates, the Nordic region fell short in attracting sizable deals in 1Q20 but instead witnessed a growing focus on start-ups and medium enterprises, a trend that is likely to continue. 

Global dealmaking has been brought to a standstill in the past few weeks and activity is likely to remain subdued for the coming months, according the Mergermarket's Q1 global M&A trend report. 

Dealspeak pitches forward from an announced deal to explore its ramifications and point to potential M&A activity.

Due to the constantly changing nature of the Coronavirus outbreak, the advice for attendees to upcoming events depends on its location and the advice of local authorities. Please check here for the latest information. 

European financial services companies experienced lower levels of M&A in 2019 versus the year before both in terms of transaction volume and value, according to Mergermarket data. However, industry dealmakers are tipped to remain busy, as insurers and banks review their operations while bourses and private equity investors scout for deals.

The Pharma, Medical and Biotech (PMB) sector has seen a significant rise in the value of deals in 2019, despite a slowdown in M&A activity

Consumer sector M&A activity in 2019 fared better in Europe than in the rest of the world